next generation diagnostics
Aptamers are suitable for a broad range of applications
The successful development of an ‘immunoassay’ is dependent upon the antibodies being highly specific and having a high affinity for their target. Cross-reactivity with other targets is often one of the biggest drawbacks of antibody diagnostic development. Aptamers can be tailored to have the required specificity, reducing downstream optimisation/screening. Aptamers can also be developed in a wider variety of matrices. Aptamers can be developed under a wider variety or conditions than is possible with antibodies. This simplifies assay development in complex matrices. Aptamer Diagnostics have the technical expertise to provide you with highly functional monoclonal and polyclonal aptamers in record time at reasonable costs.
Work with us
Aptamer Diagnostics Ltd is a collaborative company. We welcome R&D and commercialisation collaboration opportunities with industry and academic partners. If you have an idea or if you would like to discuss any potential collaboration opportunities please contact us (for more information see partnering page).